A startup has developed an application that can detect the first signs of Alzheimer’s disease

It is a fun application called ‘Overcome’ that the startup ‘Hometrix Health’ has just launched in collaboration with a neuroscience laboratory.

In France, 900,000 people suffer from Alzheimer’s disease. In the United States, it is possible to do a ‘recreational genomics’ test. If the latter is prohibited in France, it makes it possible to determine the genetic risk markers for certain diseases such as Alzheimer’s disease.

A drug also in phase 3

The French company AB Science is developing a drug (masitinib) for the treatment of Alzheimer’s disease. The company has received approval from European agencies and it is now the turn of the American health authority, the FDA, to authorize the launch of the phase 3 study, the last step before marketing.

Exercises for over 65s

For its part, startup Hometrix Health (dedicated to e-health) offers the ‘Overcome’ application; it makes it possible to identify the first signs of the disease by compiling exercises intended for the over 65s: memory exercises, timed tests, etc.

Thanks to these exercises, it becomes possible to discover the profiles at risk and to offer care as quickly as possible. To date and as reported by La Tribune (subscription article), the application is being tested with volunteers.

10% of people over 65 and 6.2% of the working population

Alzheimer’s disease represents more than 70% of neuro-evolutionary diseases in seniors and if nothing is done by 2050 it will represent nearly 10% of those over 65 and 6.2% of the active population. .

Note that Hometrix Health carries the AITIO project, which is the expert companion for people with long and complex illnesses, in particular cancer.